Manchester-based QV Bioelectronics secures over €2 million for its revolutionary brain tumour treatment

Published on January 10, 2023

QV Bioelectronics, the startup behind innovative treatments for brain tumours, has just raised over €2.2 million to fuel the development of its surgically implanted Electric Field Therapy (EFT) device. The deeptech startup is now planning to scale, bringing this treatment closer to patients.  Cancer is, sadly, an all-too-familiar illness. While the hunt continues for a…

This content is for members only. Visit the site and log in/register to read.

The post Manchester-based QV Bioelectronics secures over €2 million for its revolutionary brain tumour treatment appeared first on EU-Startups.

Continue reading on website
Other news

10 awesome Austrian startups to watch in 2023!

January 10, 2023
Boasting world-famous coffee shop culture, incredibly rich cultural heritage, and beautiful landscapes, Austria is a hub of inspiration and innovation. The Alpine nation has historically been at the intersection of European activity and is a trendsetter when it comes to innovation. A strongly industrialized nation with a strategic location in terms of research, development and… This content is for

3 Under-the-Radar Tech Stocks to Buy This January

January 10, 2023
Despite inflationary pressures and uncertain macroeconomic conditions, the tech industry is well-positioned to achieve significant growth this year, driven by increased tech spending worldwide. Given the industry’s promising growth prospects,...